| Patent application number | Description | Published |
|---|
| 20090053141 | COMPOSITIONS AND METHODS FOR MAGNETIC RESONANCE IMAGING CONTRAST AGENTS - The present application provides for compositions and methods of creating and applying contrast agents that find use in magnetic resonance imaging (MRI). In particular, contrast agents that comprise monodisperse, protein polymer backbones capable of chelating multiple paramagnetic ions resulting in high relaxivity for use in enhancing MRI signal intensity. | 02-26-2009 |
| 20090173640 | Electronic methods for the detection of analytes - The present invention is directed to the detection of target analytes using electronic techniques, particularly AC techniques. | 07-09-2009 |
| 20090196829 | MRI CONTRAST AGENTS AND RELATED METHODS OF USE - The present invention relates to contrast agents for MRI and related methods of use. | 08-06-2009 |
| 20090242430 | Electronic Methods for the Detection of Analytes - The present invention is directed to the detection of target analytes using electronic techniques, particularly AC techniques. | 10-01-2009 |
| 20090269284 | CONTRAST AGENTS - The present invention relates generally to multimodal magnetic resonance imaging (MRI) contrast agents. In particular, the present invention provides a MRI contrast agent configured to manipulate both the longitudinal (T | 10-29-2009 |
| 20100029909 | COMPOSITIONS AND METHODS COMPRISING MAGNETIC RESONANCE CONTRAST AGENTS - The present invention relates to compositions and methods for imaging with magnetic resonance contrast agents. In particular, the present invention provides targeted contrast agents for selective imaging. | 02-04-2010 |
| 20100038262 | Detection of Analytes Using Reorganization Energy - The invention relates to novel methods and compositions for the detection of analytes using the nuclear reorganization energy, λ, of an electron transfer process. | 02-18-2010 |
| 20100298415 | TARGETED SCHIFF BASE COMPLEXES - The present invention provides targeted Schiff base complexes. In particular the present invention provides biopolymer targeted transition metal complexes configured to inhibit the activity of targeted proteins, methods of synthesis thereof, and pharmaceutical compositions and uses thereof. | 11-25-2010 |
